"아스트라제네카 백신, 남아공 변이에 효과 제한적"
The results of a small-scale study suggest that the COVID-19 vaccine made by AstraZeneca... provides only limited protection from the variant of the virus from South Africa.
That's according to the Financial Times, citing the results ahead of their publication.
It said that among the study's two-thousand participants, there were no hospitalizations or deaths.
In response to the report, a spokesperson for AstraZeneca said in a statement that the study did show limited efficacy against mild COVID-19 primarily due to the South Africa variant.
The spokesperson also highlighted the small size of the study and the fact that the participants had a relatively young age... of 31, on average.
#Africa #COVID19 #variant
The results of a small-scale study suggest that the COVID-19 vaccine made by AstraZeneca... provides only limited protection from the variant of the virus from South Africa.
That's according to the Financial Times, citing the results ahead of their publication.
It said that among the study's two-thousand participants, there were no hospitalizations or deaths.
In response to the report, a spokesperson for AstraZeneca said in a statement that the study did show limited efficacy against mild COVID-19 primarily due to the South Africa variant.
The spokesperson also highlighted the small size of the study and the fact that the participants had a relatively young age... of 31, on average.
#Africa #COVID19 #variant
- Kategorien
- Gesundheits Tipps
Kommentare deaktiviert.